Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Molecular and Cellular Biology
|
November 5, 2014
The RASSF1A tumor suppressor regulates XPA-mediated DNA repair
Howard Donninger, Jennifer Clark, Francesca Rinaldo, et al.
Oncoimmunology
|
January 23, 2015
Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells
Jun Yan, Goetz Kloecker, Chris Fleming, et al.
Cancer Research
|
September 5, 2006
Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer
Jan S Sunde, Howard Donninger, Kongming Wu, et al.
Molecular and Cellular Biology
|
April 7, 2010
The Ras effector RASSF2 controls the PAR-4 tumor suppressor
Howard Donninger, Luke Hesson, Michele Vos, et al.
The Journal of Biological Chemistry
|
October 10, 2025
RALGEF inhibitors suppress RAS-driven pancreatic cancer and metastasis
Howard Donninger, Rachel Ferrill, Becca von Baby, et al.
Science Advances
|
June 30, 2023
Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy
Omar S Sarkar, Howard Donninger, Numan Al Rayyan, et al.
Cancer Cell
|
December 8, 2009
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2
Samuel C Mok, Tomas Bonome, Vinod Vathipadiekal, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Molecular and Cellular Biology
|
November 5, 2014
The RASSF1A tumor suppressor regulates XPA-mediated DNA repair
Howard Donninger, Jennifer Clark, Francesca Rinaldo, et al.
Oncoimmunology
|
January 23, 2015
Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells
Jun Yan, Goetz Kloecker, Chris Fleming, et al.
Cancer Research
|
September 5, 2006
Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer
Jan S Sunde, Howard Donninger, Kongming Wu, et al.
Molecular and Cellular Biology
|
April 7, 2010
The Ras effector RASSF2 controls the PAR-4 tumor suppressor
Howard Donninger, Luke Hesson, Michele Vos, et al.
The Journal of Biological Chemistry
|
October 10, 2025
RALGEF inhibitors suppress RAS-driven pancreatic cancer and metastasis
Howard Donninger, Rachel Ferrill, Becca von Baby, et al.
Science Advances
|
June 30, 2023
Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy
Omar S Sarkar, Howard Donninger, Numan Al Rayyan, et al.
Cancer Cell
|
December 8, 2009
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2
Samuel C Mok, Tomas Bonome, Vinod Vathipadiekal, et al.
Page
of 5